Stimulant Use in Pregnancy: An Under-recognized Epidemic Among Pregnant Women
- PMID: 30601144
- PMCID: PMC6438363
- DOI: 10.1097/GRF.0000000000000418
Stimulant Use in Pregnancy: An Under-recognized Epidemic Among Pregnant Women
Abstract
Stimulant use, including cocaine, methamphetamines, ecstasy, and prescription stimulants, in pregnancy is increasingly common. In the United States, stimulants are the second most widely used and abused substances during pregnancy and pregnant women using stimulants in pregnancy are at increased risk of adverse perinatal, neonatal, and childhood outcomes. In this review, we describe the pharmacology, pathophysiology, and epidemiology of stimulants, summarize the maternal and neonatal effects of perinatal stimulant use, and outline treatment options for stimulant use disorders among pregnant women. Development of effective treatment strategies for stimulant use disorders identified among pregnant women are urgently needed.
Conflict of interest statement
References
-
- Center for Behavioral Health Statistics Quality. 2015 National survey on drug use and health: Detailed tables In:2016.
-
- Fisher BL, Schauer P. Medical and surgical options in the treatment of severe obesity. The American journal of surgery 2002;184(6):S9–S16. - PubMed
-
- Arnsten AF. Stimulants: therapeutic actions in ADHD. Neuropsychopharmacology 2006;31(11):2376. - PubMed
-
- Gyllenhaal C, Merritt SL, Peterson SD, Block KI, Gochenour T. Efficacy and safety of herbal stimulants and sedatives in sleep disorders. Sleep Med Rev 2000;4(3):229–251. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
